Search
ca888亚洲城 is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference.
Our industry-leading medicines are approved for the treatment of certain types of Hodgkin lymphoma, urothelial cancer, and breast cancer.
We partner with healthcare professionals and academic institutions to investigate promising new therapies through clinical trials.
Our pipeline is designed with patients in mind, focusing on therapies that have the potential to address significant unmet medical needs.
Deepen your knowledge
Healthcare professionals in the United States can find recent scientific and clinical resources on our medical affairs website, including congress presentations, videos about our science, and more.
Explore the Medical Affairs WebsiteRequest additional information about our medicines, or report an adverse event or product complaint.
We support transparency of our data from completed clinical trials or for our commercially available products.
Request support for clinical research that advances medical or scientific knowledge about ca888亚洲城’s products or clinical candidates.
Learn about our grants for medical education programs that promote clinical excellence and better health outcomes.